Medical/Pharmaceuticals
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with sparsentan resulted in a reduction of proteinuria that was sustained through 108 weeks of treatment S...
2023-05-03 00:22
3147
iHerb Names Miriee Chang as Chief Operating Officer
Newly established role will further streamline operations and enhance operational effectiveness IRVINE, Calif., May 3, 2023 /PRNewswire/ -- iHerb Holdings, LLC, announced that Miriee Chang has been named its Chief Operating Officer (COO). Mrs. Chang brings significant leadership experience to th...
2023-05-03 00:14
2575
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis
* First patient dosed with CK0803 Treg cells for treatment of amyotrophic lateral sclerosis (ALS). * Ongoing Phase 1/1b study evaluating safety and efficacy of CK0803. HOUSTON, May 3, 2023 /PRNewswire/ -- Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic...
2023-05-03 00:07
1900
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne
HANGZHOU and SHAOXING, China, May 2, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that ASC40 (Denifanstat), a first-in-class, once-daily oral fatty acid synthase (FASN) inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acn...
2023-05-02 17:30
2816
Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology
* Combined broad and differentiated portfolio with trusted technologies and commercial and service organizations * Customers will have simpler and greater access to industry-leading expertise, tools, and services AMERSHAM, United Kingdom, May 2, 2023 /PRNewswire/ -- Cytiva and the life scienc...
2023-05-02 12:01
3151
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide
MELBOURNE, Australia, May 2, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged inCanada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for i...
2023-05-02 05:00
2118
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
TAMPA, Fla., May 1, 2023 /PRNewswire/ -- The US FDA has granted an
Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel
MagicTouch
2023-05-01 18:30
2556
Zimmer Biomet Announces Acquisition of OSSIS
SINGAPORE, May 1, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as wel...
2023-05-01 12:00
4696
GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023
–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date – – Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innova...
2023-05-01 11:00
2985
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalT...
2023-05-01 08:58
2492
European Wellness Collaborates with Heidelberg University in Journal Publications of "Synergistic Anti-Ageing Through Senescent Cells Specific Reprogramming"
HEIDELBERG, Germany, April 28, 2023 /PRNewswire/ -- European Wellness Academy (EWA), an educational arm of European Wellness Biomedical Group (EW Group), has collaborated with Heidelberg University on journal publication. The research project, titled "Synergistic Anti-Ageing Through Senescent Cel...
2023-04-28 11:58
2530
HOYA Vision Care Elevates Children's Protection Against Myopia & Intensive Light With MiYOSMART Sun Lenses
SINGAPORE, April 28, 2023 /PRNewswire/ -- HOYA Vision Care
2023-04-28 11:18
2493
Brii Bio Publishes 2022 Environmental, Social and Governance Report
Brii Bio receives an "A" grade in the latest MSCI ESG Rating
DURHAM, N.C. and BEIJING, April 28, 2023 /PRNewswire/ -- Brii Biosciences
Limited
2023-04-28 09:00
2640
OrthAlign's 50th Patent Affirms Position as A Global Leader in Surgical Navigation
ALISO VIEJO, Calif., April 28, 2023 /PRNewswire/ -- OrthAlign® Inc., a global leader in orthopedic surgical navigation technology, continues to expand its IP portfolio, with its 50th patent being issued. OrthAlign pioneered and continues to enhance surgical navigation solutions proven to enable a...
2023-04-28 04:33
2147
RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine
GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc.(the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance from the Uni...
2023-04-28 00:29
2785
Steakholder Foods® 3D Bio-Prints First Ready-to-Cook Cultivated Grouper Fish
Steakholder Foods 3D bio-printed the world's first cultivated fish fillet: * The Company has reached a significant milestone by successfully customizing bio-inks utilizing grouper cells provided by Umami Meats' to print a cultivated grouper product – a significant step towards the commercializa...
2023-04-27 23:50
4433
Fapon Biotech Announces Chemiluminescence One-Stop Solution Strategy in India at Medical Fair India 2023
NEW DELHI, April 27, 2023 /PRNewswire/ -- Fapon Biotech Inc. (Fapon Biotech, or the Company), a global leading IVD enterprise, has announced its innovative chemiluminescence one-stop solution strategy at the 28th edition of Medical Fair India. Fapon chemiluminescence one-stop solution is designe...
2023-04-27 18:44
1905
Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board
SHANGHAI, April 27, 2023 /PRNewswire/ -- On April 27th Beijing time, Qiming Venture Partners' portfolio company MedSci Healthcare Holdings Limited ("MedSci"), a leading physician digital platform inChina, successfully listed on the main board of Hong Kong Stock Exchange. MedSci (02415.HK)'s issue...
2023-04-27 15:53
2949
Bactiguard Holding AB's report for the first quarter 2023
Continued focus on growth and transformation STOCKHOLM, April 27, 2023 /PRNewswire/ -- First quarter 2023, January-March * Revenues amounted to SEK 61.2 (55.2) million, an increase of 11%. Adjusted for currency effects, revenues decreased by 4%. * Operating loss amounted to SEK 18.7 (16.6) ...
2023-04-27 14:47
1776
BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines
MIAMI and ADELAIDE, Australia, April 27, 2023 /PRNewswire/ -- BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a$5.0m AUD grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to fund wor...
2023-04-27 12:15
2142
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
8907
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
8266
Where does China's production capacity come from?
2024-05-10 12:01
8102
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4991